Salvianolic Acid A Protects H9C2 Cardiomyocytes from Doxorubicin-Induced Damage by Inhibiting NFKB1 Expression Thereby Downregulating Long-Noncoding RNA (lncRNA) Plasmacytoma Variant Translocation 1 (PVT1)

Yumeng Wu; Wei Xiu; Yubo Wu

doi:10.12659/MSM.929824

21 June 2021 : Laboratory Research

Salvianolic Acid A Protects H9C2 Cardiomyocytes from Doxorubicin-Induced Damage by Inhibiting NFKB1 Expression Thereby Downregulating Long-Noncoding RNA (lncRNA) Plasmacytoma Variant Translocation 1 (PVT1)

Yumeng Wu^1ABF, Wei Xiu^2CD, Yubo Wu^1AEF*

DOI: 10.12659/MSM.929824

Med Sci Monit 2021; 27:e929824

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 The effect of salvianolic acid A (SalA) on doxorubicin (Dox)-induced apoptosis in H9C2 cells. (A, B) Representative images (×200) and quantitative analysis for TUNEL staining in H9C2 cells. (C) The expression of proteins related to apoptosis in H9C2 cells was detected by western blot. ** P<0.01; *** P<0.001; # P<0.05; ### P<0.001.

Back to the Article

Salvianolic Acid A Protects H9C2 Cardiomyocytes from Doxorubicin-Induced Damage by Inhibiting NFKB1 Expression Thereby Downregulating Long-Noncoding RNA (lncRNA) Plasmacytoma Variant Translocation 1 (PVT1)

Your Privacy